Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Hezode

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Journal of Hepatology|February 19, 2008
Environmental factors as disease accelerators during chronic hepatitis CAriane Mallat, Christophe Hezode, Sophie Lotersztajn
Gastroenterologie Clinique Et Biologique|November 16, 2002
[Pegylated interferons: pharmacological basis]Isabelle Macquin-Mavier, Christophe Hezode, Daniel Dhumeaux
Alimentary Pharmacology & Therapeutics|October 29, 2020
Letter: now is the time to remove complexity from HCV guidelines to ensure that elimination remains a priorityJuan Turnes, Christophe Hezode, Candido Hernandez, et al.
Journal of Hepatology|October 9, 2013
Reply to: From the CUPIC study: great times are not coming (?)Fabrice Carrat, Yoann Barthe, Christophe Hezode, et al.
Gastroenterologie Clinique Et Biologique|February 11, 2004
[Steasis and hepatitis C]Christophe Hezode, Laurent Castera, Philippe Chouteau, et al.
Journal of Hepatology|January 1, 2014
Reply to: "From the CUPIC study: great times are not coming(?)"Christophe Hezode, Helene Fontaine, Yoann Barthe, et al.
The Journal of Infectious Diseases|January 6, 2007
The nonstructural 5A protein of hepatitis C virus genotype 1b does not contain an interferon sensitivity-determining regionRozenn Brillet, François Penin, Christophe Hezode, et al.
The American Journal of Gastroenterology|March 4, 2005
Hepatitis C virus-induced hepatocellular steatosisLaurent Castera, Philippe Chouteau, Christophe Hezode, et al.
Gastroenterologie Clinique Et Biologique|March 31, 2007
[Endocannabinoids: therapeutic perspectives in chronic liver diseases]Sophie Lotersztajn, Fatima Teixeira-Clerc, Christophe Hezode, et al.
Gastroenterology|February 28, 2004
Antiviral action of ribavirin in chronic hepatitis CJean-Michel Pawlotsky, Harel Dahari, Avidan U Neumann, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Journal of Hepatology|February 19, 2008
Environmental factors as disease accelerators during chronic hepatitis CAriane Mallat, Christophe Hezode, Sophie Lotersztajn
Gastroenterologie Clinique Et Biologique|November 16, 2002
[Pegylated interferons: pharmacological basis]Isabelle Macquin-Mavier, Christophe Hezode, Daniel Dhumeaux
Alimentary Pharmacology & Therapeutics|October 29, 2020
Letter: now is the time to remove complexity from HCV guidelines to ensure that elimination remains a priorityJuan Turnes, Christophe Hezode, Candido Hernandez, et al.
Journal of Hepatology|October 9, 2013
Reply to: From the CUPIC study: great times are not coming (?)Fabrice Carrat, Yoann Barthe, Christophe Hezode, et al.
Gastroenterologie Clinique Et Biologique|February 11, 2004
[Steasis and hepatitis C]Christophe Hezode, Laurent Castera, Philippe Chouteau, et al.
Journal of Hepatology|January 1, 2014
Reply to: "From the CUPIC study: great times are not coming(?)"Christophe Hezode, Helene Fontaine, Yoann Barthe, et al.
The Journal of Infectious Diseases|January 6, 2007
The nonstructural 5A protein of hepatitis C virus genotype 1b does not contain an interferon sensitivity-determining regionRozenn Brillet, François Penin, Christophe Hezode, et al.
The American Journal of Gastroenterology|March 4, 2005
Hepatitis C virus-induced hepatocellular steatosisLaurent Castera, Philippe Chouteau, Christophe Hezode, et al.
Gastroenterologie Clinique Et Biologique|March 31, 2007
[Endocannabinoids: therapeutic perspectives in chronic liver diseases]Sophie Lotersztajn, Fatima Teixeira-Clerc, Christophe Hezode, et al.
Gastroenterology|February 28, 2004
Antiviral action of ribavirin in chronic hepatitis CJean-Michel Pawlotsky, Harel Dahari, Avidan U Neumann, et al.
Pageof 4